We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 27th:
Grupo Financiero Galicia SA (GGAL - Free Report) : This financial services company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 9.4% over the last 60 days.
DanaosCorporation (DAC - Free Report) : This shipping company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 7.9% over the last 60 days.
Group 1 Automotive, Inc. (GPI - Free Report) : This automotive retailer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.5% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Value Stocks to Buy for September 27th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 27th:
Grupo Financiero Galicia SA (GGAL - Free Report) : This financial services company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 9.4% over the last 60 days.
Grupo Financiero Galicia S.A. Price and Consensus
Grupo Financiero Galicia S.A. price-consensus-chart | Grupo Financiero Galicia S.A. Quote
Grupo Financiero has a price-to-earnings ratio (P/E) of 2.95 compared with 10.40 for the industry. The company possesses a Value Score of B.
Grupo Financiero Galicia S.A. PE Ratio (TTM)
Grupo Financiero Galicia S.A. pe-ratio-ttm | Grupo Financiero Galicia S.A. Quote
DanaosCorporation (DAC - Free Report) : This shipping company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 7.9% over the last 60 days.
Danaos Corporation Price and Consensus
Danaos Corporation price-consensus-chart | Danaos Corporation Quote
Danaos has a price-to-earnings ratio (P/E) of 1.04 compared with 2.00 for the industry. The company possesses a Value Score of A.
Danaos Corporation PE Ratio (TTM)
Danaos Corporation pe-ratio-ttm | Danaos Corporation Quote
Group 1 Automotive, Inc. (GPI - Free Report) : This automotive retailer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.5% over the last 60 days.
Group 1 Automotive, Inc. Price and Consensus
Group 1 Automotive, Inc. price-consensus-chart | Group 1 Automotive, Inc. Quote
Group 1 Automotive has a price-to-earnings ratio (P/E) of 8.71 compared with 32.00 for the industry. The company possesses a Value Score of A.
Group 1 Automotive, Inc. PE Ratio (TTM)
Group 1 Automotive, Inc. pe-ratio-ttm | Group 1 Automotive, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>